Sandbox ammu: Difference between revisions
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
'''Treatment''' | '''Treatment''' | ||
:* Preferred regimen: | :* Preferred regimen: | ||
:: Note | :: Note<ref name="pmid25349312">{{cite journal| author=Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM et al.| title=Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. | journal=Pediatrics | year= 2014 | volume= 134 | issue= 5 | pages= e1474-502 | pmid=25349312 | doi=10.1542/peds.2014-2742 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25349312 }} </ref> | ||
::* Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally | ::* Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally | ||
::* Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis. | ::* Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis. | ||
Revision as of 18:53, 16 June 2015
Bronchiolitis
Treatment
- Preferred regimen:
- Note[1]
- Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally
- Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis.
- Clinicians should not administer epinephrine to infants and children with a diagnosis of bronchiolitis.
- Clinicians should not administer systemic corticosteroids to infants with a diagnosis of bronchiolitis in any setting.
- Clinicians should not administer antibacterial medications to infants and children with a diagnosis of bronchiolitis unless there is a concomitant bacterial infection, or a strong suspicion of one.
Prophylaxis
- Preferred regimen:
- Note
- Clinicians should not administer palivizumab to otherwise healthy infants with a gestational age of 29 weeks, 0 days or greater.
- All people should disinfect hands before and after direct contact with patients, after contact with inanimate objects in the direct vicinity of the patient, and after removing gloves.
- All people should use alcoholbased rubs for hand decontamination when caring for children with bronchiolitis. When alcoholbased rubs are not available, individuals should wash their hands with soap and water.
- Clinicians should counsel caregivers about exposing the infant or child to environmental tobacco smoke and smoking cessation when assessing a child for bronchiolitis.
- ↑ Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM; et al. (2014). "Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis". Pediatrics. 134 (5): e1474–502. doi:10.1542/peds.2014-2742. PMID 25349312.